Induction of Sustained Clinical Remission in Early Axial Spondyloarthritis Following Certolizumab Pegol Treatment: 48-Week Outcomes from C-OPTIMISE

INTRODUCTION: Achievement of remission is a key treatment goal for patients with axial spondyloarthritis (axSpA). C-OPTIMISE assessed achievement of sustained clinical remission in patients with axSpA, including radiographic (r) and non-radiographic (nr) axSpA, during certolizumab pegol (CZP) treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Landewé, Robert, van der Heijde, Désirée, Dougados, Maxime, Baraliakos, Xenofon, Van den Bosch, Filip, Gaffney, Karl, Bauer, Lars, Hoepken, Bengt, de Peyrecave, Natasha, Thomas, Karen, Gensler, Lianne S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7410911/
https://www.ncbi.nlm.nih.gov/pubmed/32529495
http://dx.doi.org/10.1007/s40744-020-00214-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7410911/
https://www.ncbi.nlm.nih.gov/pubmed/32529495
http://dx.doi.org/10.1007/s40744-020-00214-7

Ejemplares similares